Effect of candesartan, a type I angiotensin II receptor antagonist, on bronchial hyper-responsiveness to methacholine in patients with bronchial asthma

AIMS: Angiotensin II is a putative mediator in bronchial asthma. There have been very few studies investigating the involvement of angiotensin II receptors in bronchial hyper-responsiveness in asthmatic patients. We examined the effect of candesartan cilexetil, a specific angiotensin II type 1 (AT1)...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Myou, Shigeharu, Fujimura, Masaki, Kamio, Yumie, Kita, Toshiyuki, Watanabe, Kazuyoshi, Ishiura, Yoshihisa, Hashimoto, Takuma, Nakao, Shinji
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Blackwell Science Inc 2002
Konular:
Pharmacodynamics
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC1874492/
https://ncbi.nlm.nih.gov/pubmed/12492610
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller